Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros

Tipo del documento
Intervalo de año
1.
Ieee Access ; 10:104169-104177, 2022.
Artículo en Inglés | Web of Science | ID: covidwho-2070272

RESUMEN

Specific 5G Release 17 work items are dealing with critical medical applications. Moreover, the adoption of mobile health (m-health) and e-health has been accelerated by the COVID-19 pandemic. This paper first examines the requirements of critical medical applications that 5G is expected to support. Then it illustrates possible data protection, management, and privacy issues. Finally, it shows a first implementation of an m-health framework supporting physical distance management. Experimental results show that, by exploiting 5G connectivity and the computing capacity provided by an accelerated edge cloud, the proposed framework can detect physical distance violations faster than a user equipment (UE)-based implementation, while saving UE energy.

2.
2021 IEEE International Mediterranean Conference on Communications and Networking, MeditCom 2021 ; : 94-99, 2021.
Artículo en Inglés | Scopus | ID: covidwho-1700162

RESUMEN

In 5G Release 17 specific work items are dealing with medical applications. Moreover, the COVID-19 pandemic has accelerated the adoption of mobile-health (m-health) and e-health. This paper proposes the implementation of a m-health framework supporting social distancing management. Experimental results show that by exploiting 5G connectivity and the computational power provided by an accelerated edge cloud, the proposed framework can perform social distancing verification faster than a user equipment (UE)-based deployment. © 2021 IEEE.

3.
BioLaw Journal ; 2021(SpecialIssue 2):139-155, 2021.
Artículo en Inglés | Scopus | ID: covidwho-1341982

RESUMEN

In the EU, the race to find Covid-19 treatment solutions has been going hand in hand with the acceleration of authorisation procedures for medicines and medical devices, and regulatory actions to monitor promising off-label and compassionate uses. This arguably contributes to the ongoing blurring of the borderlines between research and clinical practice monitoring. This article aims to map the ethical and legal implications of this trend for data protection and informed consent in pre-marketing and post-marketing studies on medicines and medical devices in the context of the Covid-19 public health emergency. © 2021

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA